Search

In this paper, we have collected the data about the 507 high-cited (citations ≥ 25) papers on Covid 19 published by India using Scopus database. Within small span of time many papers have received considerable number of citations. Further we have analyzed in terms of types of papers, major funding agencies, major collaborating countries, prolific authors, productive organizations and cluster analysis of author supplied keywords. Most of the papers were research articles. Department of Science and Technology, Govt. of India has funded considerable numbers of papers on Covid 19 and K. Dhama form Indian Veterinary Research Institute has contributed highest numbers papers and USA was major collaborating country and PGIMER-Chandigarh was most contributing organization. This study will be useful to the scientist/researchers to know the characteristics of high cited papers on Covid-19 from India. [ABSTRACT FROM AUTHOR]

Background: As a global pandemic, Covid-19 has aroused great concern and garnered research interest world-wide In India a growing number of related researches have been published in the last few months. Therefore, a bibliometric analysis of these publications may provide indication of current status and future research trends in the field. Methods: The India's literature about Covid-19 published during 2019-2021 were searched in the Scopus database using a well-defined search strategy. The following keywords "Covid 19" or "2019 novel coronavirus" or "coronavirus 2019" or "coronavirus disease 2019" or "2019-novel CoV" or "2019 ncov" or covid 2019 or covid19 or "corona virus 2019" or ncov-2019 or ncov2019 or "nCoV 2019" or 2019-ncov or covid-19 or "Severe acute respiratory syndrome coronavirus 2" or "SARS-CoV-2"were used in "Keyord" and "Title" (Title of articles) tags to reach the relevant publications. VOSviewer was applied to perform the bibliometric analysis of these articles. Results: The bibliometric analysis of India's literature on Covid-19 indicates that there were 10,233 indexed publications in Scopus database until April 2021. Of all these publications, 52.87% were original articles and 11.75% (1202) publications received external funding from more than 150 agencies and 27.41% (2805) involve international collaboration with more than 150 countries. USA contributed the largest share (38.47%) in India's international collaborative papers, followed by U.K. (22.89%), China (11.55%), Saudi Arabia (11.44), Australia (11.23%), etc. In the geographical distribution, Delhi tops the publication list (with 21.86% share), followed by Mumbai (7.30%), Chennai (7.27%), Pune (6.44%) and Kolkata (6.04%). Among population age groups, "Adults" accounts for the largest publication share (9.98%), followed by "Middle Aged" (5.07%), "Children" (3.65%), "Aged" (3.65%) and "Adolescents" (2.82%). "Treatment studies" among prominent topics, account for the largest publication share (34.12% share), followed by "Clinical Studies" (13.13%), "Epidemiology" (10.54%), "Imaging and Diagnostics" (9.64%), "Pathophysiology" (6.27%), and etc. The 1311 organizations and 3413 authors participated in India's research on Covid-19, of which the top 30 organizations and authors contributed 43.50% and 11.57% national publication share and 45.62% and 32.14% national citation share. AIIMS-New Delhi and PGIMER-Chandigarh were the most productive organizations (with 623 and 468 papers). IVRIBareilly (21.32 and 4.44) and IIT-New Delhi (12.37 and 2.58) were the most impactful organizations. V. Wiwanitkit and K. Dhama were the most productive authors (with 182 and. 107 papers). R. Sah (42.89 and 8.93) and A. Misra (41.93 and 8.74) were the most impactful authors. International Journal of Research in Pharmaceutical Sciences (270 papers) and Indian Journal of Ophthalmology (210 papers) were the most productive journals. Science of the Total Environment (43.98) and Asian Journal of Psychiatry (19.19) were the most impactful journals. Conclusion: The paper provides a deeper understanding of the current Covid-19 research milieu in India, by identifying key players (and their collaboration linkages) and key sub-fields, while highlighting potential patterns that could assist future researchers in their scientific pursuits. [ABSTRACT FROM AUTHOR]

Objectives: The main objective of this research is to identify highly cited papers in clinical pharmacology and to analyze their publication and citation data to study their citation characteristics, and understand what role contributing authors, participating research organizations as well as international collaborative countries play in Indian clinical pharmacology research. Design: The publications output of Indian clinical pharmacology papers published during 2000-14 were screened in Scopus database and highly cited papers, with at least 100 citations since publication, were identified and shortlisted for their bibliometric analysis. The statistics cover collaboration across authors, institutions, foreign participating countries in the publication of highly cited papers. To assess comparative contributions of authors/organizations, a new indicator, the Major Contributor Index (MCI), was used. Citation trends for all papers, as well as for top papers, are presented. Results: A total of 76 highly cited articles, constituting 1.45% share of world highly cited papers output and 0.75% share of India's publications output, were published by India in clinical pharmacology output during 2000-14. This study covered only those papers that received at least 100 citations since publication. In recent years, top-cited articles have reached their citation peak in the early years of their citation life cycle, but have shown a more-rapid decreasing trend compared to top-cited articles from past decades. These 76 highly articles have received 14059 citations, with an average citation per paper of 184.99. The leading Indian organizations participating in highly cited research papers were All India Institute of Medical Sciences, New Delhi (7 papers), Panjab University, Chandigarh (6 papers), Jadavpur University, Kolkata (5 papers), National Institute of Mental Health & Allied Sciences, Bangalore, Aligarh Muslim University, Annamalai University, Banaras Hindu University, Varanasi, Sathyabama University, Guru Jambeshwar University, Hisar, Post Graduate Institute of Medical Education & Research, Chandigarh, Institute of Life Sciences, Bhubaneswar and Drug Research & Development Center, Kolkata (2 papers each). The leading authors were S.K. Bhattacharya (3 papers), J.K. Grover, S.P. Yadav, S. Garg, A.K. Singla, A.Garg, S. Ghosal, A. Bhattacharya, S. Khanna, A. Bhattacharya, S. Praveen and S.K.Sahoo (2 papers each). The leading international collaborative countries were USA (10 papers), Germany and U.K. (3 papers each), Japan, Russia Federation, Belgium and Canada (2 papers each). The MCI varied among leading organizations, as well as among individual authors. Conclusions: The output of highly cited papers by Indian authors in clinical pharmacology is still not significant given the fact that 208 authors contributed only one paper each once in 15 years, 11 contributed two papers each once in 15 years, and 1 contributed three papers once in 15 years. India still ranks 10th highest country with 1.45% share to the world output of highly cited papers compared to 61.41% share by USA. The quality of research in clinical pharmacology in India is though growing significantly over time, but there is very little evidence of corresponding growth in publication rate of highly cited papers in India. [ABSTRACT FROM AUTHOR]

The present study examines 579 Indian publications on "Migraine" research as covered in Scopus database during 2006-15, experiencing an annual growth rate of 17.37%, citation impact per paper of 8.32, international collaborative publication share of 9.80% and global publication share of 2.56%. The global publications share on "Migraine" came from several countries, of which the top 10 most productive countries accounted for 75.30% share of global publications output during 2006-15. A large number of Indian organizations and authors participated in Indian research on "Migraine" research during 2006-15, of which the top 15 organizations and 15 authors contributed 31.26% and 25.22% publications share and 70.50% and 23.50% citation share respectively of the Indian output and citations. Medicine, among subjects, contributed the largest publications (63.90%), followed by pharmacology, toxicology & pharmaceutics (34.72%), neurosciences (14.16%), biochemistry, genetics & molecular biology (13.64%) and chemistry (3.97%) during 2006-15. Indian publications on migraine research appeared in several journals, of which the top 15 journals contributed 32.64% share of the India's output. The top 14 highly cited papers registered 53 to 1087 citations, and together contributed 2094 citations, leading to the average citation per paper of 149.57. Concludes that there is an urgent need to frame a national policy in this area, undertake more R&D and recognize migraine research as a public health problem and allocate more healthcare funds in this area. [ABSTRACT FROM AUTHOR]

Present a bibliometric analysis of 1432 publications in Indian research in atypical antipsychotic drugs during 1998-2013, using publications indexed in Scopus database. The study identified the global publication share and rank of Indian research output among the 15 most productive countries and examined the distribution of citations of the Indian research output, the share of international collaborative publications in Indian publication output and identification of the leading India's collaborating partners, the distribution of Indian research output by broad subject areas, by individual drugs and by disease; publication productivity and the citation impact of leading Indian institutions; the media of communication and the characteristics of the high cited publications. [ABSTRACT FROM AUTHOR]

The current pandemic situation due to Covid-19 has put every researcher on their toes to discover new methods (whether medicine or tools and techniques) to overcome the menace from the human population. The research focus has given the generation of enormous amount of both published literature and raw research data. The research impact analysis with the help of traditional method is a time-consuming process, resulted in choosing alternative methods of impact measurement - now popularly known as Altmetric. The article analyses social media metrics of Indian publications on Covid-19 through altmetric approaches. The data for the study has been taken from Scopus and Altmetric.com and analysis was carried out for different social media activities to calculate the Altmetric attention score for Indian published literatures. An analysis was also carried out to assess whether the alternative metrics have any correlation with the citation impact. It is found that correlation between some of the social media activities and citations is highly significant. [ABSTRACT FROM AUTHOR]